The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy
- 18 February 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 32 (2), 236-239
- https://doi.org/10.1016/s0090-8258(89)80040-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.Proceedings of the National Academy of Sciences, 1986
- Astatine-211—Tellurium Radiocolloid Cures Experimental Malignant AscitesScience, 1981
- Radiocolloids in the Treatment of Ovarian CancerObstetrical & Gynecological Survey, 1979
- The effect of volume on the distribution of substances instilled into the peritoneal cavityGynecologic Oncology, 1978